ǸԹ

Skip to main content
Guidance

Tuberculosis screening

Tuberculosis (TB) screening and early detection methods, for professionals working with at-risk populations in the UK.

Tuberculosis (TB) screening and early detection methods, for professionals working with at-risk populations in the UK.

Tuberculosis (TB)is an infectious disease which can have a slow onset of symptoms and cause poor outcomes for individuals if left untreated. Despite almost all forms ofTBbeing curable, difficulties in detectingTBmake screening forTBan important action in the UK. Globally, the estimated that 10.7 million people fell ill with TB in 2024 with 1.23 million deaths globally, the top cause of death by an infectious disease.

Screening a population forTBinvolves identifying otherwise healthy people who are at an increased risk of developingTB. Thethat people who are at increased risk ofTBare screened in the UK.

Screening forTBcan focus on detecting activeTBdisease and latentTBinfection (LTBI). People withLTBIhave no symptoms of disease but are at risk of their latent infection activating into activeTB 徱𲹲.LTBIcan be detected using tuberculin skin tests (TST) or interferon gamma release assays blood test (IGRA). Screening for activeTBdisease of the lungs usually involves a symptom check and chest X-rays.

The incidence ofTBin England ishigher than most other Western European countries. It is important that awareness is raised aboutTBamongst professionals and the public. TheTuberculosis (TB) Action Plan for England, 2021 to 2026recognises that screening for latent and active forms ofTB, alongside awareness raising activities will contribute to lowering the incidence ofTBin England.

TBactive case finding

Active case finding (ACF) is a strategy used to identify and treat people withTBwho would otherwise not seek prompt medical care.ACFusually focuses on detecting pulmonaryTBusing chest X-rays or performing a symptom check.

Abnormal results may lead to the collection of patient sputum for further tests. Early detection ofTBimproves treatment outcomes and prevents the spread of the disease.

In low incidence countries,ACFis most commonly targeted at high-risk groups;. In the UK,ACFis performed on:

  • close contacts of patients withactive TB
  • people with social risk factors such as:
    • homeless people
    • people with drug and/or alcohol problems
    • prisoners
  • migrants from countries whereTBis common
  • professionals at risk ofTB(for example healthcare workers)

In some groups, especially the homeless,mobile digital x-ray units are sometimes used forACF. This can offer enhanced services including detection, diagnosis and care as well as screening for other relevant conditions.

TBawareness raising

Raising awareness makes healthcare professionals and members of the public more alert of the risk and the various clinical manifestations ofTB. This is important because:

  • TBcan be vague
  • TBcan occur in many different sites in the body
  • The onset ofTBcan be slow and is not always clear

Maintaining increased awareness ofTBcan be done through activities such as:

  • Community group outreach events
  • Training sessions
  • Production and promotion of information and educational materials in various formats and languages

See below for further information:

  • and with educational material onTB(available in different languages)
  • and information for those affected byTB
  • for professionals working with the general population andhigh-risk groups
  • international awareness raising for (24th March)

Educational materials should be in a format and language that target groups can understand. In the UK, several organisations are involved with awareness raising activities including.

LatentTBinfection (LTBI)

People withLTBIare asymptomatic and well but can become unwell as a result of reactivation of the latent TB infection. This can occur months, years or even decades after initial infection. It is likely thatLTBIreactivation causes most of the active cases in the UK.

Individuals who were born or spend considerable time in a country whereTBis very common are more likely to haveLTBI. More information aboutTBin migrants can be found in theTBmigrant health guide.

It is not feasible or cost-effective to screen an entire population forLTBIbutscreening for specific high-risk groups in the UK. These groups include:

  • close contacts of patients withTB
  • healthcare workers
  • immunosuppressed patients (for example those withHIV)
  • migrants from countries whereTBis common

TheTuberculosis (TB) Action Plan for England, 2021 to 2026recommends systematicLTBItesting and treatment for 16 to 35 year olds who recently arrived in the UK from high incidence countries as a key strategy.

Pre-entry TB screening for migrants

The tuberculosis (TB) pre-entry screening programme has been operational in 101 countries since replacing on-entry screening at UK airports in March 2014. The programme screens for active pulmonary TB (infectious form) using chest X-ray (CXR) and symptom review, with sputum testing conducted for individuals whose CXR is considered consistent with TB.

Applicants who apply for a long-term UK visa (6 months or more) and have recently lived in a country with high TB incidence (over 40/100,000), must be screened for pulmonary TB. Visa applications can only be processed once the applicant has been issued with a certificate of clearance to show they’re free from active pulmonary TB. The TBscreening for the UK leaflet explains the processes and requirements for pre-entry screening.

Screening can only be performed by a UK-recognised and quality assured provider. UKHSA works closely with the Home Office to support the development of quality assurance systems to ensure that the pre-entry TB screening programme is ‘fit for purpose’ in providing its stated objectives. The UK tuberculosis technical instructions explain the pre-departure screening programme for applicants to the UK and provide guidance for those who conduct TB screening.

The UK is one of 5 countries (alongside Australia, Canada, New Zealand and USA) that have adopted a pre‑entry TB screening programme.

Pre-entry TB screening contributes to reduction of TB in the UK . However, pre-entry screening can only detect TB among people with active pulmonary disease at the time of screening. Therefore, it is important that migrants arriving in the UK and the professionals working with them are made aware of the issues surrounding TB and opt into latent TB screening if eligible.

For more information view Tuberculosis in England, 2025 report - ǸԹ

Updates to this page

Published 23 July 2014
Last updated 10 March 2026 show all updates
  1. Updated global figures and rewritten some sections for clarity.

  2. Updated page with latest information, resources and reports.

  3. Added links to the new toolkit for new entrant latent tuberculosis programme and TB Migrant health guide.

  4. Updated link to map of TB cllnics that screen long-term visa applicants.

  5. First published.

Sign up for emails or print this page